Multidrug-resistant TB in Zambia: Review of national data from 2000 to 2011

Tropical Medicine and International Health

Volumn 18, Issue 11, 2013, Pages 1386-1391

  Kapata, Nathan ^a,b,d   Chanda Kapata, Pascalina ^a   Bates, Matthew ^b,e   Mwaba, Peter ^a   Cobelens, Frank ^c   Grobusch, Martin P ^d   Zumla, Alimuddin ^b,e  

^a MINISTRY OF HEALTH   (Zambia)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnosis; Multidrug resistant tuberculosis; Retreatments; Surveillance; Tuberculosis; Zambia

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

CHILD; DRUG RESISTANCE; FEMALE; HEALTH POLICY; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC HEALTH; TUBERCULOSIS;

ARTICLE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MULTIDRUG RESISTANT TUBERCULOSIS; PUBLIC HEALTH; RETREATMENT; SEX RATIO; TUBERCULOSIS CONTROL; ZAMBIA;

ZAMBIA;

DIAGNOSIS; MULTIDRUG-RESISTANT TUBERCULOSIS; RETREATMENTS; SURVEILLANCE; TUBERCULOSIS; ZAMBIA;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CHILD; DISEASE MANAGEMENT; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RIFAMPIN; SEX FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; ZAMBIA;

EID: 84886241724     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12183     Document Type: Article

References (23)

1. Bates M, O'Grady J, Mwaba P et al. (2012) Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One 7, e40774.
2. Bates M, O'Grady J, Maeurer M et al. (2013) Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. The Lancet Infectious Diseases 13, 36-42.
3. Cooke GS, Beaton K, Lessells RJ et al. (2011) International Spraed of MDR TB from Tugela Ferry South Africa. Emerging Infectious Diseases 17, 2035-2037.
4. Gandhi NR, Nunn P, Dheda K et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375, 1830-1843.
5. Habeenzu C, Mitarai S, Lubasi D et al. (2007) Tuberculosis and multidrug resistance in Zambian prisons, 2000-2001. International Journal of Tuberculosis and Lung Disease 11, 1216-1220.
6. Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T & Kielmann K (2013). 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Tropical Medicine and International Health 18, 1128-1133.
7. Kapata N, Chanda-Kapata P, O'Grady J et al. (2011) Trends of Zambia's tuberculosis burden over the past two decades. Tropical Medicine and International Health 16, 1404-1409.
8. Kapata N, Chanda-Kapata P, Grobusch MP et al. (2012) Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Tropical Medicine and International Health 17, 760-766.
9. Klinkenberg E, den van Hof S, Tursynbayeva A et al. (2012) Integration of HIV testing in tuberculosis drug resistance surveillance in Kazakhstan and Kenya [Short communication]. The International Journal of Tuberculosis and Lung Disease 16, 615-617.
10. Maurya AK, Kant S, Nag VL, Kushwaha RAS & Dhole TN (2012) Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. Journal of Postgraduate Medicine 58, 185-189.
11. Mulenga C, Chonde A, Bwalya IC et al. (2010) Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberculosis Research and Treatment 2010, Article ID: 938178.
12. Muyoyeta M, Schaap JA, De Haas P et al. (2009) Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory. The International Journal of Tuberculosis and Lung Disease. 13, 460-465.
13. Mwaba P, Maboshe M, Chintu C et al. (2003) The relentless spread of tuberculosis in Zambia-trends over the past 37 years (1964-2000). South African Medical Journal 93, 149-152.
14. O'Grady J, Bates M, Chilukutu L et al. (2012) Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. Clinical Infectious Diseases 55, 1171-1178.
15. Orenstein EW, Basu S, Shah NS et al. (2009) Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet Infectious Diseases 9, 153-161.
16. Raviglione MC & Pio A (2002) Evolution of WHO Policies for tuberculosis control, 1948-2001. The Lancet 135, 775-780.
17. WHO (2010). Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. World Health Organization, Geneva.
18. WHO (2012a). 2011/2012 Tuberculosis Global Fact Sheet. World Health Organization, Geneva.
19. WHO (2012b). Global Tuberculosis Report 2012. World Health Organization, Geneva.
20. Wright A, Zignol M, Van DA et al. (2009) Epidemiology of anti-tuberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. The Lancet 373, 1861-1873.
21. Zignol M, van Gemert W, Falzon D et al. (2012a) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bulletin of the World Health Organization 90, 111-119.
22. Zignol M, Sismanidis C, Falzon D, Glaziou P, Dara M & Floyd K (2012b) Multidrug-resistant tuberculosis in children: evidence from global surveillance. European Respiratory Journal [Epub ahead of print].
23. Zumla A, Abubakar I, Raviglione M et al. (2012) Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. Journal of Infectious Diseases 205, S228-S240.